Bullish option flow detected in Iovance Biotherapeutics with 6,933 calls trading, 1.2x expected, and implied vol increasing over 8 points to 119.03%. Jan-24 11 calls and Jan-25 20 calls are the most active options, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 0.11. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IOVA:
- Iovance clinical hold does not impact other trials, says JMP Securities
- Iovance expects to quickly address clinical hold, says Barclays
- Iovance PDUFA not impacted, upside still ahead despite clinical hold, says Baird
- H.C. Wainwright cuts Iovance target, says hold does not impact lifileucel
- Iovance (NASDAQ:IOVA) Nosedives on Clinical Hold for Lung Cancer Therapy